Nonenzymatic Asn Deamidation of GAD65 Generates HLA-DRB1*03:01–Restricted Neoepitopes in Type 1 Diabetes

GAD65-reactive antibodies are common in individuals with DRB1*03:01 haplotypes and diabetes, and benefits from GAD65 therapy are linked to DRB1*03:01 genotypes. DRB1*03:01 prefers Asp in binding pocket 4, such that Asn deamidation, a modification documented in islets, could generate neoepitopes. DRB1*03:01 should present GAD65 epitopes, but few have been reported. We aimed to identify DRB1*03:01-restricted GAD65 epitopes recognized in individuals with type 1 diabetes (T1D). We defined wild-type and Asn-deamidated GAD65 epitopes that are bound by DRB1*03:01 and assessed their immunogenicity through in vitro T-cell assays. In total, three deamidated and four unmodified GAD65 peptides elicited detectable T-cell responses in individuals with T1D. T-cell clones and lines recognizing each GAD65 epitope were isolated and studied, demonstrating that Asn-deamidated GAD65 epitopes are recognized with higher affinity than unmodified GAD65 epitopes. Furthermore, islet-derived T cells from pancreatic organ donors with T1D recognized Asn-deamidated and unmodified GAD65 epitopes. In total, our work identifies wild-type and deamidated epitopes that drive GAD65-specific T-cell responses in individuals positive for DRB1*03:01. These epitopes can now be applied to characterize GAD65-specific T-cell responses during diabetes progression and in the setting of clinical trials. ARTICLE HIGHLIGHTS: DRB1*03:01 is associated with GAD65 autoantibodies and immune modulation with GAD65 protein, but few reliable epitopes have been reported. We aimed to identify relevant GAD65 epitopes recognized in individuals positive for DRB1*03:01. We identified regions of GAD65 that are recognized by CD4+ T cells in individuals with DRB1*03:01 haplotypes and type 1 diabetes, including wild-type and Asn-deamidated epitopes. T cells recognized deamidated GAD65 with higher affinity than wild-type GAD65. GAD65-specific T cells are present among islet-derived T cells from pancreatic organ donors, suggesting a direct role in islet autoimmunity.

Authors

Institutions

Publication Details

Journal
Diabetes
Published
2026-11-16
DOI
https://doi.org/10.2337/db26-0296
Primary Topic
Diabetes and associated disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Nonenzymatic Asn Deamidation of GAD65 Generates HLA-DRB1*03:01–Restricted Neoepitopes in Type 1 Diabetes

Erandi Velarde de la Cruz, Anthony Manganaro, Sally C. Kent, Chantal Mathieu et al.
Diabetes
Diabetes and associated disorders
article

Nonenzymatic Asn Deamidation of GAD65 Generates HLA-DRB1*03:01–Restricted Neoepitopes in Type 1 Diabetes

Erandi Velarde de la Cruz, Anthony Manganaro, Sally C. Kent, Chantal Mathieu, Eddie A. James, Anthony R. Jones, Aïsha Callebaut, Lut Overbergh
article en

Abstract

GAD65-reactive antibodies are common in individuals with DRB1*03:01 haplotypes and diabetes, and benefits from GAD65 therapy are linked to DRB1*03:01 genotypes. DRB1*03:01 prefers Asp in binding pocket 4, such that Asn deamidation, a modification documented in islets, could generate neoepitopes. DRB1*03:01 should present GAD65 epitopes, but few have been reported. We aimed to identify DRB1*03:01-restricted GAD65 epitopes recognized in individuals with type 1 diabetes (T1D). We defined wild-type and Asn-deamidated GAD65 epitopes that are bound by DRB1*03:01 and assessed their immunogenicity through in vitro T-cell assays. In total, three deamidated and four unmodified GAD65 peptides elicited detectable T-cell responses in individuals with T1D. T-cell clones and lines recognizing each GAD65 epitope were isolated and studied, demonstrating that Asn-deamidated GAD65 epitopes are recognized with higher affinity than unmodified GAD65 epitopes. Furthermore, islet-derived T cells from pancreatic organ donors with T1D recognized Asn-deamidated and unmodified GAD65 epitopes. In total, our work identifies wild-type and deamidated epitopes that drive GAD65-specific T-cell responses in individuals positive for DRB1*03:01. These epitopes can now be applied to characterize GAD65-specific T-cell responses during diabetes progression and in the setting of clinical trials. ARTICLE HIGHLIGHTS: DRB1*03:01 is associated with GAD65 autoantibodies and immune modulation with GAD65 protein, but few reliable epitopes have been reported. We aimed to identify relevant GAD65 epitopes recognized in individuals positive for DRB1*03:01. We identified regions of GAD65 that are recognized by CD4+ T cells in individuals with DRB1*03:01 haplotypes and type 1 diabetes, including wild-type and Asn-deamidated epitopes. T cells recognized deamidated GAD65 with higher affinity than wild-type GAD65. GAD65-specific T cells are present among islet-derived T cells from pancreatic organ donors, suggesting a direct role in islet autoimmunity.

Diabetes
University of Massachusetts Chan Medical School (US), Benaroya Research Institute (US), KU Leuven (BE)
Good health and well-being
Diabetes and associated disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon